Jessica L. Mega, MD, and Susan E. Morano have joined the Boston Scientific Corporation board of directors. Jessica L. Mega, MD Dr. Mega is the co-founder of Verily Life Sciences,…
Jessica L. Mega, MD, and Susan E. Morano have joined the Boston Scientific Corporation board of directors. Jessica L. Mega, MD Dr. Mega is the co-founder of Verily Life Sciences,…
…US News & World Report “honor roll” for best care, the networks they belonged to showed substantial variation in care.[6] A recent study on practice variation in JAMA Health Forum…
…US News & World Report “honor roll” for best care, the networks they belonged to showed substantial variation in care.[6] A recent study on practice variation in JAMA Health Forum…
On June 6, the FDA released E6(R3) Guideline for Good Clinical Practice, a draft guidance with updated recommendations for good clinical practices (GCPs) aimed at modernizing the design and conduct…
On June 6, the FDA released E6(R3) Guideline for Good Clinical Practice, a draft guidance with updated recommendations for good clinical practices (GCPs) aimed at modernizing the design and conduct…
The Association for the Advancement of Medical Instrumentation (AAMI) and the British Standards Institute (BSI) have jointly published guidance documents on performing risk management for machine learning (ML) or artificial…
The Association for the Advancement of Medical Instrumentation (AAMI) and the British Standards Institute (BSI) have jointly published guidance documents on performing risk management for machine learning (ML) or artificial…
…Meta, and Microsoft have all of the data, so how can others ever compete in AI? The good news about data is that every company has deep knowledge in their…
…Meta, and Microsoft have all of the data, so how can others ever compete in AI? The good news about data is that every company has deep knowledge in their…
…news for wearable device developers is, we have decades of experience and entire families of stick-to-skin PSAs to draw on as we attempt to address the latest challenges presented by…
…news for wearable device developers is, we have decades of experience and entire families of stick-to-skin PSAs to draw on as we attempt to address the latest challenges presented by…
On May 10, the FDA released two discussion papers on the use of artificial intelligence and machine learning (AI/ML) in drug development and manufacturing. In a statement introducing the papers,…
On May 10, the FDA released two discussion papers on the use of artificial intelligence and machine learning (AI/ML) in drug development and manufacturing. In a statement introducing the papers,…
The FDA has published a new draft guidance on the use of decentralized clinical trials (DCT), which it defines as a clinical trial where some or all of the trial-related…
The FDA has published a new draft guidance on the use of decentralized clinical trials (DCT), which it defines as a clinical trial where some or all of the trial-related…
…long run. References: [1] DIHK (2022). Gesundheitswirtschaft unter Druck. https://www.dihk.de/resource/blob/73350/4912206cdf7717fd3e770a3927f58537/gesundheitsreport-fruehsommer-2022-data.pdf [2] Obelis Group (2022): What are the effects of the implementation of MDR on the EU medical device market? https://www.obelis.net/news/what-are-the-effects-of-the-implementation-of-mdr-on-the-eu-medical-device-market/…
…long run. References: [1] DIHK (2022). Gesundheitswirtschaft unter Druck. https://www.dihk.de/resource/blob/73350/4912206cdf7717fd3e770a3927f58537/gesundheitsreport-fruehsommer-2022-data.pdf [2] Obelis Group (2022): What are the effects of the implementation of MDR on the EU medical device market? https://www.obelis.net/news/what-are-the-effects-of-the-implementation-of-mdr-on-the-eu-medical-device-market/…
On the heels of the EPA’s announcement of two new proposed rules to reduce ethylene oxide (EtO) emissions, Jeff Shuren, M.D., J.D., director of the FDA CDRH, announced a radiation…
On the heels of the EPA’s announcement of two new proposed rules to reduce ethylene oxide (EtO) emissions, Jeff Shuren, M.D., J.D., director of the FDA CDRH, announced a radiation…
